Evidence map›Paper›PMID 31428103›Full record

ArticleFrontiers in immunology2019

The Caspase Inhibitor Z-VAD-FMK Alleviates Endotoxic Shock via Inducing Macrophages Necroptosis and Promoting MDSCs-Mediated Inhibition of Macrophages Activation.

Xuehui Li, Xiaoying Yao, Yuzhen Zhu, Hui Zhang, Haiyan Wang, Qun Ma, Fenglian Yan, Yonghong Yang, Junfeng Zhang, Hui Shi and 9 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Cell death in sepsis: unveiling new perspectives on organ dysfunction.Frontiers in cell and developmental biology · 2026
    Review
  7. Review
  8. Induced necroptosis limitsInfection and immunity · 2025
    Article
  9. Review
  10. Review
  11. Synthetic RIG-I-Agonist RNA Induces Death of Hepatocellular Carcinoma Cells.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 2 countries.

Xuehui LiCheeloo College of Medicine, Shandong University, Jinan, China.
Xiaoying YaoInstitute of Immunology and Molecular Medicine, Jining Medical University, Jining, China.
Yuzhen ZhuInstitute of Immunology and Molecular Medicine, Jining Medical University, Jining, China.
Hui ZhangInstitute of Immunology and Molecular Medicine, Jining Medical University, Jining, China.
Haiyan WangInstitute of Immunology and Molecular Medicine, Jining Medical University, Jining, China.
Qun MaInstitute of Immunology and Molecular Medicine, Jining Medical University, Jining, China.
Fenglian YanInstitute of Immunology and Molecular Medicine, Jining Medical University, Jining, China.
Yonghong YangDepartment of Central Laboratory, Affiliated Hospital of Jining Medical University, Jining, China.
Junfeng ZhangInstitute of Immunology and Molecular Medicine, Jining Medical University, Jining, China.
Hui ShiInstitute of Immunology and Molecular Medicine, Jining Medical University, Jining, China.
Zhaochen NingInstitute of Immunology and Molecular Medicine, Jining Medical University, Jining, China.
Jun DaiInstitute of Immunology and Molecular Medicine, Jining Medical University, Jining, China.
Zhihua LiInstitute of Immunology and Molecular Medicine, Jining Medical University, Jining, China.
Chunxia LiInstitute of Immunology and Molecular Medicine, Jining Medical University, Jining, China.
Fei SuInstitute of Animal Husbandry and Veterinary Sciences, Zhejiang Academy of Agricultural Sciences, Hangzhou, China.
Yin XueZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
Xiangzhi MengDepartment of Microbiology, Immunology, and Molecular Genetics, University of Texas Health Science Center at San Antonio, San Antonio, TX, United States.
Guanjun DongInstitute of Immunology and Molecular Medicine, Jining Medical University, Jining, China.
Huabao XiongDepartment of Medicine, Icahn School of Medicine at Mount Sinai, Precision Immunology Institute, New York, NY, United States.
Jining Medical University · CNAffiliated Hospital of Jining Medical University · CNIcahn School of Medicine at Mount Sinai · USShandong University · CNThe University of Texas Health Science Center at San Antonio · USZheJiang Academy of Agricultural Sciences · CNZhejiang Center for Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrophages play a critical role in the pathogenesis of endotoxin shock by producing excessive amounts of pro-inflammatory cytokines. A pan-caspase inhibitor, zVAD, can be used to induce necroptosis under certain stimuli. The role of zVAD in both regulating the survival and activation of macrophages, and the pathogenesis of endotoxin shock remains not entirely clear. Here, we found that treatment of mice with zVAD could significantly reduce mortality and alleviate disease after lipopolysaccharide (LPS) challenge. Notably, in LPS-challenged mice, treatment with zVAD could also reduce the percentage of peritoneal macrophages by promoting necroptosis and inhibiting pro-inflammatory responses in macrophages.

Indexed as

Amino Acid Chloromethyl KetonesAnimalsApoptosisCaspase InhibitorsCaspasesFemaleLipopolysaccharidesMacrophage ActivationMacrophages, PeritonealMiceMice, Inbred C57BLMyeloid-Derived Suppressor CellsNecroptosisShock, SepticAmino Acid Chloromethyl Ketonesbenzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneCaspase InhibitorsCaspasesLipopolysaccharidesendotoxin shockmacrophageMDSCsnecroptosiszVAD

Identifiers

PMID31428103
PMCPMC6687755
OpenAlexW2963641856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.